| Dr Alvin Gordon Beyerlein Jr, MD | |
|
15300 S Jog Rd Ste 205, Delray Beach, FL 33446-2166 | |
| (561) 493-7200 | |
| (561) 496-7989 |
| Full Name | Dr Alvin Gordon Beyerlein Jr |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 15300 S Jog Rd Ste 205, Delray Beach, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003443011 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | ME161839 (Florida) | Primary |
| Entity Name | Medical Specialists Of The Palm Beaches Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386687580 PECOS PAC ID: 0244143758 Enrollment ID: O20031111000205 |
News Archive
In the largest non-pharmacological trial ever in children with fragile X syndrome, UC Davis researchers found that large-scale, in-home cognitive interventions are feasible and may be beneficial for individuals with the syndrome and potentially other intellectual disabilities.
A small freshwater fish found in many tropical aquariums may hold the key to unlocking one of the leading causes of respiratory diseases in humans.
Akonni Biosystems a molecular diagnostics company focused on developing and manufacturing rapid, high multiplex solutions for infectious disease testing, today announced receipt of a $435K grant from the National Institutes of Biomedical Imaging and Bioengineering at the National Institutes of Health. The award will enable Akonni to accelerate development of its hands-free, sample-to-answer system for identifying a broader range of multi-drug resistant strains of Mycobacterium tuberculosis.
The decision will affect benefits for federal employees, as well as people eligible for new coverage under the health law, and will likely lead employers in the 12 states that recognize same-sex marriages to review employee-benefit packages to make sure they don't discriminate against gay spouses and comply with the law.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved the antidepressant Cymbalta (duloxetine HCl) for the treatment of generalized anxiety disorder (GAD), a condition that affects more than 6.5 million American adults in a given year.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alvin Gordon Beyerlein Jr, MD 7593 W Boynton Beach Blvd Ste 220, Boynton Beach, FL 33437-6162 Ph: (561) 678-2652 | Dr Alvin Gordon Beyerlein Jr, MD 15300 S Jog Rd Ste 205, Delray Beach, FL 33446-2166 Ph: (561) 493-7200 |
News Archive
In the largest non-pharmacological trial ever in children with fragile X syndrome, UC Davis researchers found that large-scale, in-home cognitive interventions are feasible and may be beneficial for individuals with the syndrome and potentially other intellectual disabilities.
A small freshwater fish found in many tropical aquariums may hold the key to unlocking one of the leading causes of respiratory diseases in humans.
Akonni Biosystems a molecular diagnostics company focused on developing and manufacturing rapid, high multiplex solutions for infectious disease testing, today announced receipt of a $435K grant from the National Institutes of Biomedical Imaging and Bioengineering at the National Institutes of Health. The award will enable Akonni to accelerate development of its hands-free, sample-to-answer system for identifying a broader range of multi-drug resistant strains of Mycobacterium tuberculosis.
The decision will affect benefits for federal employees, as well as people eligible for new coverage under the health law, and will likely lead employers in the 12 states that recognize same-sex marriages to review employee-benefit packages to make sure they don't discriminate against gay spouses and comply with the law.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved the antidepressant Cymbalta (duloxetine HCl) for the treatment of generalized anxiety disorder (GAD), a condition that affects more than 6.5 million American adults in a given year.
› Verified 9 days ago
Dr. Chelsea Chapkin Albanese, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15340 S Jog Rd Ste 200, Delray Beach, FL 33446 Phone: 561-496-7200 | |
Dr. Ahmet H Lavkan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4662 Hammock Cir, Delray Beach, FL 33445 Phone: 561-254-6464 | |
Marlon Amos Labi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13593 Barcelona Lake Cir, Delray Beach, FL 33446 Phone: 954-849-4953 | |
John Receveur, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2932 Sw 22nd Cir Apt B, Delray Beach, FL 33445 Phone: 302-507-4975 | |
Rodolfo Reyes, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 N Congress Ave Ste 403, Delray Beach, FL 33445 Phone: 561-272-1618 Fax: 561-272-2880 | |
Marie Rubby Roger, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13455 S Military Trl Ste A, Delray Beach, FL 33484 Phone: 561-288-6153 Fax: 561-288-6087 |